| ID Source | ID |
|---|---|
| PubMed CID | 6440069 |
| MeSH ID | M0178233 |
| Synonym |
|---|
| bay v 3522 |
| (6r,7r)-7-[[(2r)-2-amino-2-(2-amino-1,3-benzothiazol-6-yl)acetyl]amino]-8-oxo-3-[(z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| bay v-3522 |
| 7-(2-amino-2-(2-aminobenzothiazol-6-yl-acetoamide))-3-(1-propen-1-yl)-3-cephen-4-carboxylic acid |
| 75hlv3qoh7 , |
| 7-(2-amino-2-(2-aminobenzothiazol-6-yl-acetoamide))-3-(1-propen-1-yl)-3-cephem-4-carboxylic acid |
| 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(2-amino-6-benzothiazolyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, (6r-(3(z),6alpha,7beta(r*)))- |
| 120635-27-0 |
| unii-75hlv3qoh7 |
| 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2r)-amino(2-amino-6-benzothiazolyl)acetyl)amino)-8-oxo-3-(1z)-1-propenyl-, (6r,7r)- |
| bay-v-3522 anhydrous |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| methicillin | penicillin allergen; penicillin | antibacterial drug | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
| ampicillin | beta-lactam antibiotic; penicillin allergen; penicillin | antibacterial drug | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
| amoxicillin | penicillin allergen; penicillin | antibacterial drug | 1990 | 1990 | 34.0 | medium | 0 | 0 | 2 | 0 | 0 | 0 | |
| cephalosporin c | cephalosporin | fungal metabolite | 1990 | 1991 | 33.7 | high | 0 | 0 | 9 | 0 | 0 | 0 | |
| clavulanic acid | oxapenam | antibacterial drug; anxiolytic drug; bacterial metabolite; EC 3.5.2.6 (beta-lactamase) inhibitor | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
| amoxicillin-potassium clavulanate combination | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|